Theratechnologies Inc. (THTX)
$3.39+0.00%Close
BUYBULL · day 64
Key stats
- Market cap
- $156M
- Beta
- 0.81
- P/E (TTM)
- -19.94
- 1W
- +0.00%
- 1M
- +4.63%
- vs SPY 1W
- +0.14%
- vs SPY 1M
- +2.12%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 57
- VALUE
- 23
- GROWTH
- 56
- GARP
- 80
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC21.6%
REV YoY-
ROE36.0%
EPS YoY-
ROA-15.6%
GROSS76
OP10
NET-10
[VALUATION]
P/E TTM-19.94
P/E FWD18.72
SECTOR PE20.34
INDUSTRY PE19.31
P/B-6.62
P/FCF-
EV/EBITDA28.43
EV/EBIT-
PEG0.45
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.19
ND/EBITDA-
BETA0.81
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on THTX?
- LOPJLB’s latest quantitative signal on Theratechnologies Inc. (THTX) is BUY in a BULL regime. Signals are updated daily.
- What market regime is THTX in?
- Theratechnologies Inc. (THTX) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Theratechnologies Inc. (THTX) do?
- Theratechnologies Inc. is a biopharmaceutical firm dedicated to creating and marketing a range of treatments aimed at fulfilling critical medical requirements across the United States, Canada, and Europe. Its current product portfolio includes EGRIFTA and EGRIFTA SV, designed to diminish excessive abdominal fat in HIV-positive individuals experiencing lipodystrophy. Additionally, it markets Tro…